Biomedicines (Jul 2024)

Evaluating Sex Steroid Hormone Neuroprotection in Spinal Cord Injury in Animal Models: Is It Promising in the Clinic?

  • Angélica Coyoy-Salgado,
  • Julia Segura-Uribe,
  • Hermelinda Salgado-Ceballos,
  • Tzayaka Castillo-Mendieta,
  • Stephanie Sánchez-Torres,
  • Ximena Freyermuth-Trujillo,
  • Carlos Orozco-Barrios,
  • Sandra Orozco-Suarez,
  • Iris Feria-Romero,
  • Rodolfo Pinto-Almazán,
  • Gabriela Moralí de la Brena,
  • Christian Guerra-Araiza

DOI
https://doi.org/10.3390/biomedicines12071478
Journal volume & issue
Vol. 12, no. 7
p. 1478

Abstract

Read online

The primary mechanism of traumatic spinal cord injury (SCI) comprises the initial mechanical trauma due to the transmission of energy to the spinal cord, subsequent deformity, and persistent compression. The secondary mechanism of injury, which involves structures that remained undamaged after the initial trauma, triggers alterations in microvascular perfusion, the liberation of free radicals and neurotransmitters, lipid peroxidation, alteration in ionic concentrations, and the consequent cell death by necrosis and apoptosis. Research in the treatment of SCI has sought to develop early therapeutic interventions that mitigate the effects of these pathophysiological mechanisms. Clinical and experimental evidence has demonstrated the therapeutic benefits of sex-steroid hormone administration after traumatic brain injury and SCI. The administration of estradiol, progesterone, and testosterone has been associated with neuroprotective effects, better neurological recovery, and decreased mortality after SCI. This review evaluated evidence supporting hormone-related neuroprotection over SCI and the possible underlying mechanisms in animal models. As neuroprotection has been associated with signaling pathways, the effects of these hormones are observed on astrocytes and microglia, modulating the inflammatory response, cerebral blood flow, and metabolism, mediating glutamate excitotoxicity, and their antioxidant effects. Based on the current evidence, it is essential to analyze the benefit of sex steroid hormone therapy in the clinical management of patients with SCI.

Keywords